Contract development and manufacturing organisation Vetter is executing a $100m project to expand and upgrade its filling production facilities located in Germany and the US.
The company is constructing two new filling lines to increase the production capacity of its Ravensburg South facility in Germany. The new lines will fill liquid cartridges and vials. The company also recently added a syringe line to the Ravensburg facility.
For its clinical manufacturing facility in Chicago, US, a third line for pre-filled syringes is being constructed and is nearing completion.The new line will have a maximum batch size of 30,000 and will begin operation in 2014.
Work is also ongoing to increase storage volume to improve efficiency in up and downstream processes. The company will also build two new thawing rooms in class 100,000 environments and two additional lyophilizers that will join the existing nine which are in operation.
In an effort to follow regulatory requirements, Vetter is expanding its single-use isolator technology, which was implemented at manufacturing sites to reduce the risk of product cross-contamination with high-potent compounds including hormones and cancer therapeutics.
Vetter managing director Thomas Otto said: "With these initiatives, we not only satisfy their demand for increased capacity, but continue to provide the kind of industry-leading facilities and high quality standards to be a reliable and efficient partner for our customers."